華中數控(300161.SZ):華數機器人一直在研究AI技術在工業機器人上的應用
格隆匯6月20日丨有投資者向華中數控(300161.SZ)提問,“【工信部:聚焦5G、人工智能等重點領域拓展新的應用場景實施“機器人+”應用行動】將培育壯大新興產業。將聚焦5G、人工智能、生物製造、工業互聯網、智能網聯汽車、綠色低碳等重點領域,不斷豐富和拓展新的應用場景。擴大國家制造業創新中心在新興產業領域的建設佈局。實施“機器人+”應用行動,推動物聯網產業規模化、集約化發展。請問華中機器人是否會與人工智能技術相結合,研發可語音對話的智能機器人?”
華中數控回覆稱,華數機器人一直在研究人工智能(AI)技術在工業機器人上的應用,包括智能感知、智能控制和智能服務
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.